influence on the thermodynamic stability of MPPH or its intrinsic
reactivity towards PPh3.
center and inhibits the reaction of diferrous 1 with the oxidant
MPPH. We also observe a clear dependence of the Keq value on
the nature of the corresponding alcohol. The results presented here
suggest an explanation for the depletion of the catalytic activity
observed during the oxidation of cyclohexane and indicate the
sensitivity of this catalyst towards Lewis bases.
In this paper, we report kinetic evidence that a binuclear
non-heme iron model complex capable of catalytically oxidizing
cyclohexane to cyclohexanol suffers from product inhibition. It is
therefore interesting to compare our synthetic model chemistry to
metalloenzyme systems in order to highlight differences between
homogeneous small molecule catalysts and enzyme active site
metal chemistry that is internally sequestered and environmentally
regulated by the protein matrix. Binuclear non-heme iron enzymes,
such as soluble methane monooxygenase (sMMO) or toluene
monooxygenase (TOMO), are designed and have evolved such
that they do not suffer from product inhibition under normal
conditions. sMMO possess a very broad substrate specificity and
is capable of catalyzing both oxidation and epoxidation reactions,
depending on the substrate.29 In the case of sMMO, the apparent
Km for methanol (0.95 mM) and methane (0.16 mM) have been
established suggesting that methanol has a relatively poor affinity
for the enzyme,29 consistent with the observed lack of product
inhibition. Crystallography studies of both sMMO30 and TOMO31
have shown evidence for substrate channels and cavities within
the protein structure. In the case of sMMO, two channels with
significant hydrophobic character were identified and proposed
to facilitate methane and dioxygen transport into the active site.
However, crystals grown in the presence of methanol found no
methanol molecules present in these cavities.30 These data suggest
that there might be a different pathway for methanol to leave the
active site30 in order to efficiently transport substrate and product
during catalysis. TOMO was also found to have a single channel
large enough to accommodate aromatic substrates or products to
or from the active site.31 This channel was found to contain both
hydrophobic and hydrophilic residues suggesting it may facilitate
both entrance and exit to the active site.31
Enzymes have been shown to be affected by product inhibition.
One in particular is from the related family of mononuclear
non-heme iron enzymes, tyrosine hydroxylase (TyrH).10,32,33 TyrH
catalyzes the conversion of tyrosine to L-DOPA and has been
shown to be affected by product inhibition. The product, L-DOPA
is a catechol which once synthesized by the enzyme can coordinate
to the iron center in the active site.34
The chemistry of model complexes is performed in homogenous
solution with little control over what happens to the product once
it is formed. Unlike an enzyme, which may contain substrate
channels and may undergo global structural changes designed
to release product from the active site after the reaction is
completed,35 small molecule analogs are more susceptible to
product inhibition as reactions proceed. One way to overcome
the issue of product inhibition is to develop continuous flow
catalysis methods where there is a constant flow of substrate over
the catalyst which results in product being washed away after the
reaction is completed.36 Such efforts are currently underway.
References
1 E. Y. Tshuva and S. J. Lippard, Chem. Rev., 2004, 104, 987–1011.
2 M. H. Baik, M. Newcomb, R. A. Friesner and S. J. Lippard, Chem.
Rev., 2003, 103, 2385–2419.
3 B. J. Wallar and J. D. Lipscomb, Chem. Rev., 1996, 96, 2625–2657.
4 H. Dalton, Advanced Applications of Microbiology, 1980, 48, 371–399.
5 H. Dalton, P. C. Wilkins and Y. Jiang, Biochem. Soc. Trans., 1993, 21,
749–752.
6 G. M. Whited and D. T. Gibson, J. Bacteriol., 1991, 173, 3010–3016.
7 L. M. Newman and L. P. Wackett, Biochemistry, 1995, 34, 14066–14076.
8 N. Mitic´, S. J. Smith, A. Neves, L. W. Guddat, L. R. Gahan and G.
Schenk, Chem. Rev., 2006, 106, 3338–3363.
9 D. A. Kopp and S. J. Lippard, Curr. Opin. Chem. Biol., 2002, 6, 568–576.
10 T. J. Kappock and J. P. Caradonna, Chem. Rev., 1996, 96, 2659–2756.
11 P. Nordlund and P. Reichard, Annu. Rev. Biochem., 2006, 75, 681–706.
12 P. J. Riggs-Gelasco, L. J. Shu, S. X. Chen, D. Burdi, B. H. Huynh, L.
Que Jr. and J. Stubbe, J. Am. Chem. Soc., 1998, 120, 849–860.
13 S. K. Lee, B. G. Fox, W. A. Froland, J. D. Lipscomb and E. Mu¨nck, J.
Am. Chem. Soc., 1993, 115, 6450–6451.
14 S. K. Lee, J. C. Nesheim and J. D. Lipscomb, J. Biol. Chem., 1993, 268,
21569–21577.
15 K. E. Liu, D. L. Wang, B. H. Huynh, D. E. Edmondson, A. Salifoglou
and S. J. Lippard, J. Am. Chem. Soc., 1994, 116, 7465–7466.
16 K. E. Liu, A. M. Valentine, D. L. Wang, B. H. Huynh, D. E.
Edmondson, A. Salifoglou and S. J. Lippard, J. Am. Chem. Soc., 1995,
117, 10174–10185.
17 F. C. Anson, J. A. Christie, T. J. Collins, R. J. Coots, T. T. Furutani, S.
L. Gipson, J. T. Keech, T. E. Frafft, B. D. Santarsiero and G. H. Spies,
J. Am. Chem. Soc., 1984, 106, 4460.
18 A. Stassinopoulos, G. Schulte, G. C. Papaefthymiou and J. P.
Caradonna, J. Am. Chem. Soc., 1991, 113, 8686–8697.
19 S. Mukerjee, A. Stassinopoulos and J. P. Caradonna, J. Am. Chem.
Soc., 1997, 119, 8097–8098.
20 G. T. Rowe, C. E. Rogge, E. V. Rybak-Akimova and J. P. Caradonna,
Chem.–Eur. J., 2008, 14, 8303–8311.
21 G. T. Rowe, E. V. Rybak-Akimova and J. P. Caradonna, Inorg. Chem.,
2007, 46, 10594–10606.
22 P. J. Cappillino, G. T. Rowe, P. C. Tarves, C. E. Rogge, A. M. Spuches,
A. Stassinopoulos, W. Lo, W. H. Armstrong and J. P. Caradonna, Inorg.
Chim. Acta, 2009, 262, 2136–2150.
23 T. L. Foster and J. P. Caradonna, J. Am. Chem. Soc., 2003, 125, 3678–
3679.
24 T. C. Bruice and W. A. Lee, J. Am. Chem. Soc., 1985, 107, 513–514.
25 T. C. Bruice and L. C. Yuan, J. Am. Chem. Soc., 1985, 107, 512–513.
26 R. D. Hancock, H. Maumela and A. S. de Sousa, Coord. Chem. Rev.,
1996, 148, 315–347.
27 C.-C. Su, J. W. Reed and E. S. Gould, Inorg. Chem., 1973, 12, 337–342.
28 D. R. Pesiri, D. K. Morita, T. Walker and W. Tumas, Organometallics,
1999, 18, 4916–4924.
29 J. Colby, D. I. Stirling and H. Dalton, Biochemical Journal, 1977, 165,
395–402.
30 M. H. Sazinsky, J. Bard, A. Di Donato and S. J. Lippard, J. Biol. Chem.,
2004, 279, 30600–30610.
31 D. A. Whittington, A. C. Rosenzweig, C. A. Frederick and S. J. Lippard,
Biochemistry, 2001, 40, 3467–3482.
32 P. F. Fitzpatrick, Annu. Rev. Biochem., 1999, 68, 355–381.
33 E. Solomon, I. T. C. Brunold, M. I. Davis, J. N. Kemsley, S.-K. Lee, N.
Lehnert, F. Neese, A. J. Skulan, Y.-S. Yang and J. Zhou, Chem. Rev.,
2000, 100, 235–349.
Conclusions
We present low-temperature stopped-flow kinetic evidence for
product inhibition in the oxidation of cyclohexane to cyclohexanol
during the reaction of diferrous complex 1 with MPPH. A
proposed mechanism, consistent with the observed data, contains
a pre-equilibrium step where the alcohol coordinates to the metal
34 S. Spector, R. Gordon, A. Sjoerdsma and S. Udenfriend, Molecular
Pharmacology, 1967, 3, 549–555.
35 M. H. Sazinsky and S. J. Lippard, J. Am. Chem. Soc., 2004, 127, 5814–
5825.
36 U. Hintermair, G. Francio and W. Leitner, Chem. Commun., 2011, 47,
3691–3701.
782 | Dalton Trans., 2012, 41, 777–782
This journal is
The Royal Society of Chemistry 2012
©